Achieving cysteine-selective peptide/protein bioconjugation via tunable triazine-pyridine chemistry
Science Advances · 2025
DOI: 10.1126/sciadv.aea6904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Chaoming Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs Chinese Ministry of Education, Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Cent…. Hauptthemen laut MEDLINE: Triazines, Cysteine, Peptides, Pyridines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Special funds of Shandong Province for Qingdao National Laboratory of Marine Science and Technology, Taishan Scholar Project Fund of Shandong Province, Research Grants Council-Senior Research Fellow Scheme of the Research Grants Council of Hong Kong.
Abstract (Originalsprache)
The development of cysteine (Cys)–selective bioconjugation reagents with enhanced stability remains a critical challenge for therapeutic applications such as antibody-drug conjugates (ADCs). Leveraging the modular 1,3,5-triazine scaffold, we report the design and optimization of triazine-pyridinium chemistry (TPC) reagents for selective Cys labeling. Through systematic structural modifications and computational studies, we identified reagent 9b , featuring a para - N , N -dimethylaminopyridinium leaving group and ethoxy substitution, as the most efficient and selective candidate for selective protein labeling. 9b demonstrated near-quantitative Cys labeling (>95% yield) under physiological conditions (pH 7.4) while suppressing tyrosine reactivity, a limitation of earlier TPC probes. The reagent demonstrated excellent compatibility with various peptides and proteins, including therapeutic antibodies like trastuzumab, showcasing its potential for constructing ADCs. The optimized labeling ensured robust stability of the conjugates in biological environments, highlighting the practical applicability of this methodology. Our findings underscore the promise of triazine-pyridinium chemistry in developing stable, site-specific bioconjugates for targeted therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs Chinese Ministry of Education, Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, School of Medicine and Pharmacy, Ocean University of China, Qingda…
- Center for Innovative Drug Discovery, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Shanghai, P. R. China.
- Marine Biomedical Research Institute of Qingdao, Qingdao 266237, China.
- Department of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Hong Kong SAR 999077, P. R. China.
ORCID-Profile: Chaoming Wang, Qinbo Ma, Shanyue Zheng, Rilei Yu, Han Liu, Xuechen Li, Tao Jiang
Förderung
- Special funds of Shandong Province for Qingdao National Laboratory of Marine Science and Technology
- Taishan Scholar Project Fund of Shandong Province
- Research Grants Council-Senior Research Fellow Scheme of the Research Grants Council of Hong Kong
- the Key Project of Greater Bay Area Institute of Precision Medicine
Zitieren
APA
Wang, C., Yin, R., Jiang, H., Ma, Q., Zhang, H., Zheng, S., Yu, R., Liu, H., Li, X., & Jiang, T. (2025). Achieving cysteine-selective peptide/protein bioconjugation via tunable triazine-pyridine chemistry. Science Advances. https://doi.org/10.1126/sciadv.aea6904
Vancouver
Wang C, Yin R, Jiang H, Ma Q, Zhang H, Zheng S, et al. Achieving cysteine-selective peptide/protein bioconjugation via tunable triazine-pyridine chemistry. Science Advances. 2025. doi:10.1126/sciadv.aea6904
BibTeX
@article{Wang2025,
author = {Wang, Chaoming and Yin, Ruijuan and Jiang, Hao and Ma, Qinbo and Zhang, Hongli and Zheng, Shanyue and Yu, Rilei and Liu, Han and Li, Xuechen and Jiang, Tao},
title = {Achieving cysteine-selective peptide/protein bioconjugation via tunable triazine-pyridine chemistry},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.aea6904}
}
EUVIMED